Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Work In Process (2016 - 2026)

Phibro Animal Health has reported Work In Process over the past 13 years, most recently at $29.2 million for Q4 2025.

  • For Q4 2025, Work In Process rose 11.0% year-over-year to $29.2 million; the TTM value through Dec 2025 reached $29.2 million, up 11.0%, while the annual FY2025 figure was $28.0 million, 18.82% up from the prior year.
  • Work In Process for Q4 2025 was $29.2 million at Phibro Animal Health, up from $25.8 million in the prior quarter.
  • Over five years, Work In Process peaked at $29.2 million in Q4 2025 and troughed at $10.1 million in Q3 2021.
  • A 5-year average of $20.8 million and a median of $23.0 million in 2023 define the central range for Work In Process.
  • Biggest five-year swings in Work In Process: decreased 2.74% in 2021 and later soared 72.97% in 2022.
  • Year by year, Work In Process stood at $11.9 million in 2021, then soared by 68.34% to $20.0 million in 2022, then rose by 25.27% to $25.1 million in 2023, then rose by 5.05% to $26.3 million in 2024, then rose by 11.0% to $29.2 million in 2025.
  • Business Quant data shows Work In Process for PAHC at $29.2 million in Q4 2025, $25.8 million in Q3 2025, and $28.0 million in Q2 2025.